| 产品名称： | Borrelia burgdorferi Johnson et al. emend. Baranton et al. |
|---|---|
| 商品货号： | TS205314 |
| Strain Designations： | 297 |
| Application： | Assay for antibodies
Emerging infectious disease research
Vector borne research |
| Isolation： | Cerebrospinal fluid |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Lyme disease |
| Medium： | ATCC® Medium 1914: Revised BSK medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor： | Gundersen Medical Foundation |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC <-- Gundersen Medical Foundation <-- A.C. Steere |
| References： | Steere AC, et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308: 733-740, 1983. PubMed: 6828118 Western Blot Assay for Antibodies to Borrelia burgdorferi; Approved Guideline. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M34-A. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Borrelia burgdorferi Johnson et al. emend. Baranton et al. |
|---|---|
| 商品货号： | TS205314 |
| Strain Designations： | 297 |
| Application： | Assay for antibodies
Emerging infectious disease research
Vector borne research |
| Isolation： | Cerebrospinal fluid |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Lyme disease |
| Medium： | ATCC® Medium 1914: Revised BSK medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor： | Gundersen Medical Foundation |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC <-- Gundersen Medical Foundation <-- A.C. Steere |
| References： | Steere AC, et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308: 733-740, 1983. PubMed: 6828118 Western Blot Assay for Antibodies to Borrelia burgdorferi; Approved Guideline. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M34-A. |
